Novo Nordisk (NVO) shares have lost 4.5% in the past month compared with the industry's decline of 1.5%. The company has also underperformed in the sector and the S&P 500 in the past month, as seen in the chart below. The stock is currently trading below both its 50 and 200-day moving averages. NVO Stock Underperforms the Industry, Sector & the S&P 500 Image Source: Zacks Investment Research Novo Nordisk's stock price primarily dipped after U.S. Senator Bernie Sanders criticized the company for charging hig ...